Tumor infiltrating lymphocyte grade in Merkel cell carcinoma: relationships with clinical factors and independent prognostic value

References

• Paulson KG, Park SY, Vandeven NA, et al. Merkel cell carcinoma: current US incidence and projected increases based on changing demographics. J Am Acad Dermatol. 2018;78(3):457–463.e2.
   PubMed Web of Science ®Google Scholar
• Harms PW, Harms KL, Moore PS, et al. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. Nat Rev Clin Oncol. 2018;15(12):763–776.
   PubMed Web of Science ®Google Scholar
• Becker JC, Stang A, DeCaprio JA, et al. Merkel cell carcinoma. Nat Rev Dis Primers. 2017;3:17077.
   PubMed Web of Science ®Google Scholar
• Kaufman HL, Russell J, Hamid O, et al. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Lancet Oncol. 2016;17(10):1374–1385.
   PubMed Web of Science ®Google Scholar
• Nghiem PT, Bhatia S, Lipson EJ, et al. PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma. N Engl J Med. 2016;374(26):2542–2552.
   PubMed Web of Science ®Google Scholar
• Nghiem P, Bhatia S, Lipson EJ, et al. Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy. J Clin Oncol. 2019;37(9):693–702.
   PubMed Web of Science ®Google Scholar
• Weiss SA, Han SW, Lui K, et al. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma. Hum Pathol. 2016;57:116–125.
   PubMed Web of Science ®Google Scholar
• Thomas NE, Busam KJ, From L, et al. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study. J Clin Oncol. 2013;31(33):4252–4259.
   PubMed Web of Science ®Google Scholar
• Leon-Ferre RA, Polley MY, Liu H, et al. Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer. Breast Cancer Res Treat. 2018;167(1):89–99.
   PubMed Web of Science ®Google Scholar
• Huh JW, Lee JH, Kim HR. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer. Arch Surg. 2012;147(4):366–372.
   PubMed Web of Science ®Google Scholar
• Sihto H, Böhling T, Kavola H, et al. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study. Clin Cancer Res. 2012;18(10):2872–2881.
   PubMed Web of Science ®Google Scholar
• Feldmeyer L, Hudgens CW, Ray-Lyons G, et al. Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma. Clin Cancer Res. 2016;22(22):5553–5563.
   PubMed Web of Science ®Google Scholar
• Paulson KG, Iyer JG, Tegeder AR, et al. Transcriptome-wide studies of Merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol. 2011;29(12):1539–1546.
   PubMed Web of Science ®Google Scholar
• Ricci C, Righi A, Ambrosi F, et al. Prognostic impact of MCPyV and TIL subtyping in Merkel cell carcinoma: evidence from a Large European Cohort of 95 patients. Endocr Pathol. 2020;31(1):21–32.
   PubMed Web of Science ®Google Scholar
• Behr DS, Peitsch WK, Hametner C, et al. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas. Int J Clin Exp Pathol. 2014;7(11):7610–7621.
   PubMed Web of Science ®Google Scholar
• Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–690.
   PubMed Web of Science ®Google Scholar
• Trinidad CM, Torres-Cabala CA, Prieto VG, et al. Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis. J Clin Pathol. 2019;72(5):337–340.
   PubMed Web of Science ®Google Scholar
• Jennifer Ruhl EW, Hofferkamp J. Site-Specific Data Item (SSDI) manual. Illinois: NAACCR, Springfield; 2019.
   Google Scholar
• Agarwal P, Moshier E, Ru M, et al. Immortal time bias in observational studies of time-to-event outcomes: assessing effects of postmastectomy radiation therapy using the National Cancer Database. Cancer Control. 2018;25(1):1073274818789355.
   Web of Science ®Google Scholar
• Park HS, Gross CP, Makarov DV, et al. Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(5):1365–1373.
   PubMed Web of Science ®Google Scholar
• Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol. 2011;11:129.
   PubMed Web of Science ®Google Scholar
• van Buuren S, Groothuis-Oudshoorn K. mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:67.
   Web of Science ®Google Scholar
• Robitzsch AG. miceadds: some additional multiple imputation functions, especially for 'mice'. Kiel, Germany: R package version 3.9-14. 2020.
   Google Scholar
• Team RC. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2016.
   Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12(12):1495–1499.
   PubMed Web of Science ®Google Scholar
• Andea AA, Coit DG, Amin B, et al. Merkel cell carcinoma: histologic features and prognosis. Cancer. 2008;113(9):2549–2558.
   PubMed Web of Science ®Google Scholar
• Paulson KG, Iyer JG, Simonson WT, et al. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. Am J Clin Pathol. 2014;142(4):452–458.
   PubMed Web of Science ®Google Scholar
• Walsh NM, Fleming KE, Hanly JG, et al. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma. Hum Pathol. 2016;52:190–196.
   PubMed Web of Science ®Google Scholar
• Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678–2683.
   PubMed Web of Science ®Google Scholar